Huntsman (HUN)
(Delayed Data from NYSE)
$22.05 USD
+0.10 (0.46%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $22.06 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.05 USD
+0.10 (0.46%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $22.06 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Zacks News
Huntsman (HUN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Huntsman (HUN) closed at $23.23 in the latest trading session, marking a +1.75% move from the prior day.
Huntsman (HUN) Q3 Earnings Match, Revenues Top Estimates
by Zacks Equity Research
Huntsman (HUN) is committed to balanced approach to capital allocation by growing its downstream businesses portfolio.
Huntsman (HUN) Meets Q3 Earnings Estimates
by Zacks Equity Research
Huntsman (HUN) delivered earnings and revenue surprises of 0.00% and 9.15%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Huntsman (HUN) in Q3 Earnings?
by Anindya Barman
While Huntsman (HUN) faces headwind from higher raw material costs, it should gain from growth in downstream specialty and formulation businesses in Q3.
Zacks.com featured highlights include: MGM, Huntsman, Principal Financial, Unum and Wintrust
by Zacks Equity Research
Zacks.com featured highlights include: MGM, Huntsman, Principal Financial, Unum and Wintrust
Huntsman (HUN) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pick These 5 Bargain Stocks With Alluring EV/EBITDA Ratios
by Anindya Barman
We have screened bargain stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.
Are You Looking for a High-Growth Dividend Stock? Huntsman (HUN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Huntsman (HUN) have what it takes? Let's find out.
Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman
by Zacks Equity Research
Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman
Should Value Investors Buy Huntsman (HUN) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Low Price-to-Book Stocks to Buy in a Volatile Market
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
HUN vs. APD: Which Stock Is the Better Value Option?
by Zacks Equity Research
HUN vs. APD: Which Stock Is the Better Value Option?
Are You Looking for a High-Growth Dividend Stock? Huntsman (HUN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Huntsman (HUN) have what it takes? Let's find out.
Zacks.com featured highlights include: MetLife, Stifel Financial, Rayonier Advanced, ON Semiconductor and Huntsman
by Zacks Equity Research
Zacks.com featured highlights include: MetLife, Stifel Financial, Rayonier Advanced, ON Semiconductor and Huntsman
Can Huntsman (HUN) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Huntsman (HUN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cabot (CBT) Set to Raise Global Prices of Activated Carbon
by Zacks Equity Research
Cabot (CBT) decides to raise activated carbon prices in response to escalating raw material costs and currency fluctuations.
Westlake Chemical to Acquire NAKAN, Expand Global Footprint
by Zacks Equity Research
Westlake Chemical's (WLK) latest deal enables the company to expand its compounding business globally.
Is Huntsman (HUN) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Barrick & Shandong Gold Enter Into Cross Shareholding Deal
by Zacks Equity Research
Barrick's (ABX) move to ink cross shareholding deal strengthens its partnership with Shandong Gold.
5 Reasons That Make ArcelorMittal (MT) Stock a Solid Pick Now
by Anindya Barman
Strong fundamentals and upbeat prospects make ArcelorMittal (MT) an attractive investment choice.
Boost Your Portfolio With These 5 Low P/B Ratio Stocks
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
Why Should You Add Steel Dynamics (STLD) to Your Portfolio?
by Anindya Barman
Based on its compelling prospects, we believe Steel Dynamics (STLD) has plenty of upside potential.
Eastman Chemical Raises Prices of Methanol Methyl Acetate
by Zacks Equity Research
Eastman Chemical (EMN) plans to lift list and off-list prices of Methyl Acetate in North America starting Oct 1.
Barrick, Randgold in $18.3B Merger, To Form Gold-Mining Giant
by Nilanjan Gupta
Barrick Gold's (ABX) latest deal with Randgold to create an industry-leading gold company with the highest concentration of Tier One Gold Assets.
5 Reasons That Make Cleveland-Cliffs (CLF) a Solid Pick Now
by Zacks Equity Research
Upbeat prospects along with strong fundamentals make Cleveland-Cliffs (CLF) an attractive investment choice.